
Adipogen/Albocycline/BVT-0429-M001/1 mg
商品编号:
BVT-0429-M001
品牌:
Adipogen Inc
市场价:
¥1900.00
美元价:
1140.00
产品分类:
其他试剂
公司分类:
Other_reagents
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
Product Details | |
---|---|
Synonyms | Ingramycin; Antibiotic SR 2077; Antibiotic TA 2407 |
Product Type | Chemical |
Properties | |
Formula | C18H28O4 |
MW | 308.4 |
CAS | 25129-91-3 |
Source/Host Chemicals | Isolated from Streptomyces sp. S1168. |
Purity Chemicals | ≥98% (HPLC, NMR) |
Appearance | Yellowish oil. |
Solubility | Soluble in DMSO, methanol, dichloromethane or acetone. |
Identity | Determined by 1H-NMR. |
Declaration | Manufactured by BioViotica. |
InChi Key | BYWWNDLILWPPJP-VHONNXCJSA-N |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Use/Stability |
Stable for at least 2 years after receipt when stored at -20°C. Store solutions at -20°C in the dark. |
Documents | |
MSDS |
![]() |
Product Specification Sheet | |
Datasheet |
![]() |
- 14-Membered macrolide without sugar moieties.
- Antibiotic. Selective mainly against staphylococci (incl. MRSA).
- Inhibitor of prolyl endopeptidase.
- Insecticidal activity.
- Inhibitor of nicotinic acid (nicotinate; NA) biosynthesis.
Product References
- Studies on a new antibiotic, albocycline. I. Isolation, purification and properties: N. Nagahamam, et al.; J. Antibiot. 5, 261 (1967)
- Mode of action of albocycline, an inhibitor of nicotinate biosynthesis: F. Reusser; J. Bact. 100, 11 (1969)
- Albocycline: structure determination by x-ray crystallography: R.C. Thomas & C.G. Chidester; J. Antibiot. 35, 1658 (1982)
- Biosynthesis of albocycline: origin of the carbon skeleton: A. Taddei & A. Zeeck; J. Antibiot. 50, 526 (1997)
- Albocycline- and carbomycin-type macrolides, inhibitors of human prolyl endopeptidases: C. Christner, et al.; J. Antibiot. 51, 368 (1998)
- New structural scaffold 14-membered macrocyclic lactone ring for selective inhibitors of cell wall peptidoglycan biosynthesis in Staphylococcus aureus: N. Koyama, et al.; J. Antibiot. 66, 303 (2013)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。
联络我们